Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
定义慢性 HIV 感染免疫缺陷的发病机制
基本信息
- 批准号:7934706
- 负责人:
- 金额:$ 240万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This program project application is submitted by the members of the Cleveland Immunopathogenesis Consortium (CLIC) a group of investigators representing 10 academic and research institutions in the United States and Canada who have engaged for more than three years in a coordinated research effort aimed at unraveling the mechanisms whereby HIV infection results in progressive immune deficiency. This group of experienced, outstanding investigators capitalizes on complementary research skills and resources and proposes an interdisciplinary program comprising 4 projects that are coordinated and supported by two cores: Administrative Core, charged with overall coordination and administration of the program and Specimen Acquisition Core, Alan Landay, PI, charged with assuring a sustained supply of clinical specimens of gut and lymph nodes to support project investigators. The projects comprise a series of interacting research platforms from basic laboratory research to experimental animal models to translational projects, each designed to explore the determinants and mechanisms whereby immune activation drives CD4+ T cell depletion and dysfunction in chronic HIV infection. Project #1: Bystander activation drives T cell losses in chronic HIV infection - PIs: Michael M. Lederman, M.D., Scott F. Sieg Ph.D. - Case, will test the hypothesis that increased systemic levels of microbial TLR ligands and common gamma chain cytokines in secondary lymphoid tissues drive central memory T cell activation and turnover in chronic HIV infection. Project #2: Loss of intestinal barrier function in HIV infection - Alan Levine, Ph.D. Case, will examine the integrity of the intestinal mucosa in HIV infection to document the mechanistic details underlying the enhanced translocation of microbial products through the damaged gut that we propose contributes to the pathogenesis of cell loss in chronic HIV infection. Project #3: Immune activation and AIDS pathogenesis in SIV-infected non-human primates - Guido Silvestri, M.D., Univ of Pennsylvania, will attempt to induce disease in non-pathogenic SIV infection of sooty mangabeys by activation of the innate immune system and will test whether blocking innate immune activation will attenuate disease pathogenesis in infected rhesus macaques. Project #4: Immune activation promotes PD1 expression and immune dysfunction in chronic HIV infection - Rafick Pierre Sekaly Ph.D. - Univ of Montreal, will examine the role of innate immune system activation through the interaction between HIV RNAs and TLR7/8 on the expression of PDL-1 and 2 and their effects on the function and survival of HIV reactive T cells.
描述(由申请人提供):本计划项目申请由克利夫兰免疫病理联盟(CLIC)的成员提交,CLIC是一个由代表美国和加拿大的10个学术和研究机构的研究人员组成的小组,他们三年多来一直致力于一项旨在揭示艾滋病毒感染导致进行性免疫缺陷的机制的协调研究工作。这组经验丰富、杰出的研究人员利用互补的研究技能和资源,提出了一个由两个核心协调和支持的跨学科计划:行政核心,负责计划的整体协调和管理,以及标本获取核心,负责确保持续供应肠道和淋巴结的临床标本,以支持项目研究人员。这些项目包括一系列互动研究平台,从基础实验室研究到实验动物模型再到翻译项目,每个平台都旨在探索免疫激活导致慢性HIV感染中CD4+T细胞耗尽和功能障碍的决定因素和机制。项目1:旁观者激活导致慢性HIV感染中T细胞的损失-PI:Michael M.Lederman,M.D.,Scott F.Sieg Ph.D.-Case,将测试以下假设:在慢性HIV感染中,系统中微生物TLR配体和次级淋巴组织中常见的伽马链细胞因子水平的增加推动中央记忆T细胞的激活和更新。项目2:HIV感染中肠道屏障功能的丧失-Alan Levine博士案例,他将研究HIV感染中肠道粘膜的完整性,以记录下微生物产物通过受损肠道促进转运的机制细节,我们认为这有助于慢性HIV感染中细胞丢失的发病机制。项目3:免疫激活与感染SIV的非人类灵长类动物的艾滋病发病机制-宾夕法尼亚大学医学博士Guido Silvestri将尝试通过激活固有免疫系统来诱导非致病性SIV感染烟尘猴的疾病,并将测试阻断先天性免疫激活是否会减轻受感染的恒河猴的疾病发病。项目4:免疫激活促进慢性HIV感染中PD1的表达和免疫功能障碍-蒙特利尔大学Rafick Pierre Sekaly Ph.D.将通过HIV RNAs和TLR7/8之间的相互作用来研究先天免疫系统激活对PDL-1和2表达的作用及其对HIV反应T细胞功能和生存的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL MARCEL LEDERMAN其他文献
MICHAEL MARCEL LEDERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL MARCEL LEDERMAN', 18)}}的其他基金
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
将溶细胞细胞靶向 HIV 持续存在的淋巴部位。
- 批准号:
9292706 - 财政年份:2016
- 资助金额:
$ 240万 - 项目类别:
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
将溶细胞细胞靶向 HIV 持续存在的淋巴部位。
- 批准号:
8841193 - 财政年份:2014
- 资助金额:
$ 240万 - 项目类别:
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
将溶细胞细胞靶向 HIV 持续存在的淋巴部位。
- 批准号:
8930055 - 财政年份:2014
- 资助金额:
$ 240万 - 项目类别:
Effects of IL-6 blockade in treated HIV infection
IL-6 阻断对 HIV 感染治疗的影响
- 批准号:
8617799 - 财政年份:2013
- 资助金额:
$ 240万 - 项目类别:
Effects of IL-6 blockade in treated HIV infection
IL-6 阻断对 HIV 感染治疗的影响
- 批准号:
9005805 - 财政年份:2013
- 资助金额:
$ 240万 - 项目类别:
Effects of IL-6 blockade in treated HIV infection
IL-6 阻断对 HIV 感染治疗的影响
- 批准号:
8510992 - 财政年份:2013
- 资助金额:
$ 240万 - 项目类别:
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
抑制 CCR5 预防 HIV 传播的基础和比较研究
- 批准号:
7391001 - 财政年份:2008
- 资助金额:
$ 240万 - 项目类别:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
定义慢性 HIV 感染免疫缺陷的发病机制
- 批准号:
8115015 - 财政年份:2008
- 资助金额:
$ 240万 - 项目类别:
Developing RANTES analogues as topical strategies to prevent HIV transmission
开发 RANTES 类似物作为预防 HIV 传播的局部策略
- 批准号:
7418081 - 财政年份:2008
- 资助金额:
$ 240万 - 项目类别:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
定义慢性 HIV 感染免疫缺陷的发病机制
- 批准号:
7666054 - 财政年份:2008
- 资助金额:
$ 240万 - 项目类别:
相似海外基金
Elucidation of the molecular pathogenesis of myelodysplastic syndromes: from the perspective of the cooperative action of innate immune dysregulation and inflammation in the bone marrow.
阐明骨髓增生异常综合征的分子发病机制:从先天性免疫失调与骨髓炎症协同作用的角度来看。
- 批准号:
23K14713 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel pathogenesis and therapeutic strategy of autoimmunity based on immune-tuning molecules
基于免疫调节分子的自身免疫新发病机制和治疗策略
- 批准号:
23H00438 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
使用非人灵长类动物模型来定义 T 细胞免疫反应在持续性卡波西肉瘤相关疱疹病毒感染和卡波西肉瘤发病机制中的作用
- 批准号:
10667986 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Immune evasion mechanisms and pathogenesis-related factors of mycoplasma in bovine tracheal epithelial cells.
牛气管上皮细胞支原体免疫逃避机制及发病相关因素
- 批准号:
23K05574 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting immune cells derived from tumor clones in the pathogenesis of hematological malignancy-related systemic organ failure
在血液恶性肿瘤相关的全身器官衰竭的发病机制中靶向肿瘤克隆衍生的免疫细胞
- 批准号:
23H02752 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Deciphering the roles of RIFIN and STEVOR parasite antigens in severe malaria pathogenesis via transcriptomics and immune profiling
通过转录组学和免疫分析破译 RIFIN 和 STEVOR 寄生虫抗原在严重疟疾发病机制中的作用
- 批准号:
10748822 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Elucidation of the pathogenesis of HTLV-1-related diseases with a focus on immune aging and development of novel preventive and therapeutic strategies.
阐明 HTLV-1 相关疾病的发病机制,重点关注免疫衰老和开发新型预防和治疗策略。
- 批准号:
23H02953 - 财政年份:2023
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Immune system dysfunction and gut dysbiosis in the pathogenesis of vascular dysfunction in autoimmunity
免疫系统功能障碍和肠道菌群失调在自身免疫血管功能障碍发病机制中的作用
- 批准号:
10544784 - 财政年份:2022
- 资助金额:
$ 240万 - 项目类别:
Pathogenesis of HTLV-1-associated myelopathy (HAM) by innate immune analysis and development of new treatment methods
通过先天免疫分析HTLV-1相关脊髓病(HAM)的发病机制并开发新的治疗方法
- 批准号:
22H03121 - 财政年份:2022
- 资助金额:
$ 240万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating genetic mechanisms of Clostridioides difficile pathogenesis and patient immune manipulation
阐明艰难梭菌发病机制和患者免疫操作的遗传机制
- 批准号:
10601891 - 财政年份:2022
- 资助金额:
$ 240万 - 项目类别:














{{item.name}}会员




